Company
Delix Therapeutics
Claim, correct or request removal
Record updated 17 September 2026
About
Delix develops non-hallucinogenic psychoplastogens for neuropsychiatric disorders.
Loading relationship preview
Company
Record updated 17 September 2026
Delix develops non-hallucinogenic psychoplastogens for neuropsychiatric disorders.
A first look at Delix Therapeutics’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.